Gösta Gahrton

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Hung Fan, Alessandro Aiuti, Jacqueline Corrigan-Curay, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

Richard Rosenquist, G. Gahrton, R. Rosenquist, 2005, Blood.

Identification of progression markers in B-CLL by gene expression profiling.

G. Gahrton, A. Wennborg, B. Lambert, 2005, Experimental hematology.

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Kenneth C. Anderson, Benjamin Djulbegovic, Bart Barlogie, 2003, British journal of haematology.

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Bengt Simonsson, Olle Linder, U. Olsson‐Strömberg, 2004, The hematology journal : the official journal of the European Haematology Association.

Approach to the treatment of multiple myeloma: a clash of philosophies.

P. L. Bergsagel, G. Gahrton, S. Rajkumar, 2011, Blood.

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.

G. Gahrton, H. Nahi, E. Alici, 2010, Cytotherapy.